Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Plasma Exchange Therapy on the Pharmacokinetics of Rituximab in Patients Treated for Autoimmune Disorders.

NCT00820469 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT00820469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00820469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Plasma Exchange Therapy on the Pharmacokinetics of Rituximab in Patients Treated for Autoimmune Disorders.
Lead sponsor
University Hospital, Toulouse
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2008
Completion date
January 31, 2010
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, renal transplant